The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Immunovant Inc shares valued at $778,490 were purchased by WILLIAM MACIAS on Jun 13 ’25. At $15.57 per share, WILLIAM MACIAS acquired 50,000 shares.
Also, WILLIAM MACIAS purchased 80,000 shares, netting a total of over 1,248,616 in proceeds.
Before that, GEORGE V MIGAUSKY had added 21,812 shares to its account. In a trade valued at $318,047, the Former Director bought Immunovant Inc shares for $14.58 each.
As published in their initiating research note from Jefferies on March 03, 2025, Immunovant Inc [IMVT] has been a Hold and the price target has been revised to $20. Analysts at Wolfe Research downgraded the stock from ‘”an Outperform”‘ to ‘”a Peer perform”‘ outlook in a report released in early January. Earlier on October 09, 2024, Oppenheimer resumed its rating. Their recommendation was “an Outperform” for IMVT stock.
Analyzing IMVT Stock Performance
On last trading session,, Immunovant Inc [NASDAQ: IMVT] rose 3.59% to $15.86. The stock’s lowest price that day was $15.105, but it reached a high of $15.93 in the same session. During the last five days, there has been a drop of approximately -1.80%. Over the course of the year, Immunovant Inc shares have dropped approximately -35.97%. Shares of the company reached a 52-week high of $25.79 on 01/02/25 and a 52-week low of $12.72 on 04/09/25.
Support And Resistance Levels for Immunovant Inc (IMVT)
According to the 24-hour chart, there is a support level at 15.33, which, if violated, would cause prices to drop to 14.81. In the upper region, resistance lies at 16.16. The next price resistance is at 16.46. RSI (Relative Strength Index) is 54.03 on the 14-day chart, showing neutral technical sentiment.
Is Immunovant Inc subject to short interest?
Stocks of Immunovant Inc saw a sharp rise in short interest on 2025-05-30 jumping by 0.97 million shares to 21.68 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 20.71 million shares. A jump of 4.47% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 18.43 of the overall float, the days-to-cover ratio (short ratio) jumped to 18.43.
Which companies own the most shares of Immunovant Inc (IMVT)?
In terms of Immunovant Inc share price expectations, FactSet research, analysts set an average price target of 49 in the next 12 months, up nearly 220.05% from the previous closing price of $15.31. Analysts anticipate Immunovant Inc stock to reach 57 by 2025, with the lowest price target being 5. In spite of this, 20 analysts ranked Immunovant Inc stock as Buy at the end of 2025. On March 28, 2024, Oppenheimer assigned a price target of “an Outperform” to the stock and initiated coverage with a $50.
